Product
BIIB132
1 clinical trial
1 indication
Indication
Spinocerebellar Ataxia Type 3Clinical trial
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3Status: Terminated, Estimated PCD: 2023-07-25